Top pharma M&A deals in 2005

Here's a look at the top deals in the Indian pharma sector. 

June 

Matrix Labs decides to acquire the Belgium-based $263-million pharma company Docpharma NV .

Torrent Pharma acquires Heumann Pharma GmbH & Co Generica KG, a generic drug company with the Pfizer group at a valuation of $50 mn.

October

Jubilant Organosys  picks up 100 per cent stake in a US-based CRO, Target Research Sociates Inc, in a $33.5-mn cash deal.

Nicholas Piramal India acquires UK's Avecia Pharmaceuticals for a consideration of £9.5 mn.

November

Dr Reddy's Labs acquires Roche's API business at its manufacturing site in Cuernavaca, Mexico for $59 mn

Overseas Joint Ventures 

February

Strides Arcolab acquires an additional stake of 12.5% at a cost of $6 mn in its JV, Strides Latina

July

Jubilant acquires 64% equity in the US-based generic pharmaceuticals company Trinity Labs Inc and its wholly-owned subsidiary Trigen Labs Inc for $12.25 mn

September

Nicholas Piramal India completes private placement of 7.5 lakh common shares at a price of Canadian $0.80 per share BioSyntech

October

Matrix Labs acquires  43 per cent holding in Explora Laboratories SA, based in Switzerland

November

Hikal enters into a JV by buying a minority stake in one of Sinochem Corporation's subsidiaries in China